Journal of Surgery Concepts & Practice >

2022 , Vol. 27 >Issue 01: 42 - 45

DOI: https://doi.org/10.16139/j.1007-9610.2022.01.011

Experts forum

Perineural invasion and neural plasticity in pancreatic cancer: study history and current treatment

Expand

Received date: 2021-12-01

  Online published: 2022-03-17

Fold

Cite this article

WEI Jishu, HUANG Shimeng . Perineural invasion and neural plasticity in pancreatic cancer: study history and current treatment[J]. Journal of Surgery Concepts & Practice, 2022 , 27(01) : 42 -45 . DOI: 10.16139/j.1007-9610.2022.01.011

References

[1] Batsakis JG. Nerves and neurotropic carcinomas[J]. Ann Otol Rhinol Laryngol, 1985, 94(4 Pt 1):426-427.
[2] Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15):3379-3391.
[3] Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(11):649-659.
[4] Demir IE, Ceyhan GO, Liebl F, et al. Neural invasion in pancreatic cancer: the past, present and future[J]. Cancers (Basel), 2010, 2(3):1513-1527.
[5] Fouquet T, Germain A, Brunaud L, et al. Is perineural invasion more accurate than other factors to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma?[J]. World J Surg, 2014, 38(8):2132-2137.
[6] Nagakawa T, Mori K, Nakano T, et al. Perineural invasion of carcinoma of the pancreas and biliary tract[J]. Br J Surg, 1993, 80(5):619-621.
[7] Nagakawa T, Kayahara M, Ueno K, et al. Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer[J]. Hepatogastroenterology, 1992, 39(1):51-55.
[8] Kayahara M, Nagakawa T, Ueno K, et al. Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion[J]. Surgery, 1995, 117(6):616-623.
[9] Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer[J]. Pancreas, 1996, 12(4):357-361.
[10] Yi SQ, Miwa K, Ohta T, et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer[J]. Pancreas, 2003, 27(3):225-229.
[11] Demir IE, Boldis A, Pfitzinger PL, et al. Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion[J]. J Natl Cancer Inst, 2014, 106(8): dju184.
[12] Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases[J]. Gastroenterology, 2009, 136(1):177-186.
[13] Ceyhan GO, Demir IE, Rauch U, et al. Pancreatic neuropathy results in“neural remodeling” and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer[J]. Am J Gastroenterol, 2009, 104(10):2555-2565.
[14] Iwasaki T, Hiraoka N, Ino Y, et al. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma[J]. Cancer Sci, 2019, 110(4):1491-1502.
[15] Kawarada Y. New classification of pancreatic carcinoma--Japan Pancreas Society[J]. Nihon Shokakibyo Gakkai Zasshi, 2003, 100(8):974-980.
[16] Pedrazzoli S, Dicarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group[J]. Ann Surg, 1998, 228(4):508-517.
[17] Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J]. Surgery, 2005, 138(4):618-628,628-630.
[18] Michalski CW, Kleeff J, Wente MN, et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer[J]. Br J Surg, 2007, 94(3):265-273.
[19] Nimura Y, Nagino M, Takao S, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial[J]. J Hepatobiliary Pancreat Sci, 2012, 19(3):230-241.
[20] Jang JY, Kang MJ, Heo JS, et al. A prospective rando-mized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer[J]. Ann Surg, 2014, 259(4):656-664.
[21] Demir IE, Schorn S, Schremmer-Danninger E, et al. Pe-rineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis[J]. PLoS One, 2013, 8(3):e60529.
[22] Demir IE, Kujundzic K, Pfitzinger PL, et al. Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells[J]. Proc Natl Acad Sci USA, 2017, 114(1):e85-e94.
[23] Damm M, Weniger M, Kolsch AK, et al. The quality of pain management in pancreatic cancer: a prospective multi-center study[J]. Pancreatology, 2020, 20(7):1511-1518.
[24] Okusaka T, Okada S, Ueno H, et al. Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings[J]. Pancreas, 2001, 22(3):279-284.
[25] Sahin IH, Shama MA, Tanaka M, et al. Association of diabetes and perineural invasion in pancreatic cancer[J]. Cancer Med, 2012, 1(3):357-362.
[26] Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published li-terature[J]. Ann Oncol, 2008, 19(12):1985-1991.
[27] Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer[J]. J Clin Oncol, 2014, 32(36):4149-4154.
[28] Drewes AM, Campbell CM, Ceyhan GO, et al. Pain in pancreatic ductal adenocarcinoma: a multidisciplinary, international guideline for optimized management[J]. Pancreatology, 2018, 18(4):446-457.
[29] Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle[J]. Am J Gastroenterol, 2010, 105(12):2599-2606.
[30] Luz LP, Al-Haddad MA, Dewitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: An update and controversies for the endosonographer[J]. Endosc Ultrasound, 2014, 3(4):213-220.
[31] Bang JY, Sutton B, Hawes RH, et al. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial[J]. Gastrointest Endosc, 2019, 89(1):58-66.
[32] Saloman JL, Albers KM, Li D, et al. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer[J]. Proc Natl Acad Sci USA, 2016, 113(11):3078-3083.
[33] Demir IE, Reyes CM, Alrawashdeh W, et al. Clinically actionable strategies for studying neural influences in cancer[J]. Cancer Cell, 2020, 38(1):11-14.
[34] Saloman JL, Albers KM, Rhim AD, et al. Can stopping nerves, stop cancer?[J]. Trends Neurosci, 2016, 39(12):880-889.
Options
Outlines

/

〈 〉